140 related articles for article (PubMed ID: 19287314)
1. Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
Samadi P; Rajput A; Calon F; Grégoire L; Hornykiewicz O; Rajput AH; Di Paolo T
J Neuropathol Exp Neurol; 2009 Apr; 68(4):374-82. PubMed ID: 19287314
[TBL] [Abstract][Full Text] [Related]
2. Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
Samadi P; Grégoire L; Morissette M; Calon F; Hadj Tahar A; Bélanger N; Dridi M; Bédard PJ; Di Paolo T
Neuropharmacology; 2008 Feb; 54(2):258-68. PubMed ID: 18001807
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor type 5 in levodopa-induced motor complications.
Ouattara B; Grégoire L; Morissette M; Gasparini F; Vranesic I; Bilbe G; Johns DR; Rajput A; Hornykiewicz O; Rajput AH; Gomez-Mancilla B; Di Paolo T
Neurobiol Aging; 2011 Jul; 32(7):1286-95. PubMed ID: 20036444
[TBL] [Abstract][Full Text] [Related]
4. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
[TBL] [Abstract][Full Text] [Related]
5. Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495.
Linden AM; Johnson BG; Trokovic N; Korpi ER; Schoepp DD
Neuropharmacology; 2009 Aug; 57(2):172-82. PubMed ID: 19477188
[TBL] [Abstract][Full Text] [Related]
6. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
[TBL] [Abstract][Full Text] [Related]
7. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
Julien C; Berthiaume L; Hadj-Tahar A; Rajput AH; Bédard PJ; Di Paolo T; Julien P; Calon F
Neurochem Int; 2006 Apr; 48(5):404-14. PubMed ID: 16442670
[TBL] [Abstract][Full Text] [Related]
8. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Piccini P; Weeks RA; Brooks DJ
Ann Neurol; 1997 Nov; 42(5):720-6. PubMed ID: 9392571
[TBL] [Abstract][Full Text] [Related]
9. mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
Samadi P; Grégoire L; Morissette M; Calon F; Hadj Tahar A; Dridi M; Belanger N; Meltzer LT; Bédard PJ; Di Paolo T
Neurobiol Aging; 2008 Jul; 29(7):1040-51. PubMed ID: 17353071
[TBL] [Abstract][Full Text] [Related]
10. Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
Morelli M; Di Paolo T; Wardas J; Calon F; Xiao D; Schwarzschild MA
Prog Neurobiol; 2007 Dec; 83(5):293-309. PubMed ID: 17826884
[TBL] [Abstract][Full Text] [Related]
11. Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off.
Rajput AH; Fenton ME; Di Paolo T; Sitte H; Pifl C; Hornykiewicz O
Parkinsonism Relat Disord; 2004 Jun; 10(4):221-6. PubMed ID: 15120096
[TBL] [Abstract][Full Text] [Related]
12. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Aubert I; Guigoni C; Li Q; Dovero S; Bioulac BH; Gross CE; Crossman AR; Bloch B; Bezard E
Biol Psychiatry; 2007 Apr; 61(7):836-44. PubMed ID: 16950226
[TBL] [Abstract][Full Text] [Related]
13. Optimizing pharmacotherapy: strategies to manage the wearing-off phenomenon.
Tse W
J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):12-7. PubMed ID: 17948614
[TBL] [Abstract][Full Text] [Related]
14. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Calon F; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
Neurobiol Dis; 2003 Dec; 14(3):404-16. PubMed ID: 14678757
[TBL] [Abstract][Full Text] [Related]
15. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
16. Increased metabotropic glutamate 2/3 receptor binding in the perigenual anterior cingulate cortex of Cloninger type 2 alcoholics: a whole-hemisphere autoradiography study.
Laukkanen V; Kärkkäinen O; Kupila J; Kautiainen H; Tiihonen J; Storvik M
Alcohol Alcohol; 2015 Jan; 50(1):62-7. PubMed ID: 25425009
[TBL] [Abstract][Full Text] [Related]
17. Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Calon F; Morissette M; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
Mov Disord; 2003 Mar; 18(3):241-253. PubMed ID: 12621627
[TBL] [Abstract][Full Text] [Related]
18. Novel pattern of levodopa-related motor fluctuations: 'paradoxical'on.
Kim HJ; Kim JY; Ha Paek S; Jeon BS
Parkinsonism Relat Disord; 2008; 14(4):281-5. PubMed ID: 17980642
[TBL] [Abstract][Full Text] [Related]
19. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
Lim SY; Farrell MJ; Gibson SJ; Helme RD; Lang AE; Evans AH
Mov Disord; 2008 Sep; 23(12):1689-95. PubMed ID: 18709675
[TBL] [Abstract][Full Text] [Related]
20. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
Li XY; Zhuang P; Li YJ
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
